MHRA approves the first generic raltegravir medicines to treat adult and paediatric patients infected by HIV

Twitter

Linkedin

Facebook

email

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 July 2024, approved the first generic raltegravir medicines to treat adult and paediatric HIV patients who weigh at least 40kg.

Follow this news feed: